Home › NDC Lookup › RxCUI directory › RxCUI 578803

Betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension — RxCUI 578803

RxNorm drug concept · Semantic clinical drug
RxCUI 578803 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI578803
Official nameBetamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbetamethasone 3 MG/ML (as betamethasone sodium phosphate) / betamethasone acetate 3 MG/ML Injectable Suspension; betamethasone sodium phosphate / betamethasone acetate 6 MG/ML Injectable Suspension
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)236,116 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Betamethasone Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Betamethasone topical is used for skin conditions that respond to steroid treatment — things like psoriasis, eczema, and other inflammatory skin problems that cause redness and itc...
  • What skin conditions does betamethasone topical treat?
  • Apply a small amount — a thin layer or just a few drops — directly to the affected area once or twice daily, depending on which product you have. Rub it in gently until it disappea...
  • These products are meant for short-term use. In general, you should see improvement within two weeks — if you don't, check back with your doctor rather than continuing on your own....
📖 Read our full Betamethasone Topical guide →

🕸️ Concept Web — How Betamethasone 3 MG/ML / betamethasone acetate 3... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension RxCUI 578803

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Betamethasone 1514
    • Betamethasone / betamethasone acetate 1007039
    • Betamethasone acetate 1516
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Celestone Soluspan 47847
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Betamethasone Injectable Suspension 378340
    • Betamethasone / betamethasone acetate Injectable Suspension 2646132
    • Betamethasone Injectable Product 1153796
    • Betamethasone / betamethasone acetate Injectable Product 2660089
    • Betamethasone Injectable Suspension [Celestone Soluspan] 365600
    • Betamethasone / betamethasone acetate Injectable Suspension [Celestone Soluspan] 2658397
    • Celestone Soluspan Injectable Product 1166205
    • Injectable Suspension 316950
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Betamethasone 3 MG/ML SCDC · 329583
  • Betamethasone acetate 3 MG/ML SCDC · 358827
  • Betamethasone Injectable Suspension SCDF · 378340
  • Betamethasone / betamethasone acetate Injectable Suspension SCDFP · 2646132
  • Betamethasone Injectable Product SCDG · 1153796
  • Betamethasone / betamethasone acetate Injectable Product SCDGP · 2660089

Brand-Name Concepts

📦 FDA Products & Package NDCs

12 products · 12 package NDCs
12 package NDCs map to RxCUI 578803 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00517-0720-01 1 VIAL, MULTI-DOSE in 1 CARTON (0517-0720-01) / 5 mL in 1 V... Betamethasone Sodium Phosphate and Betamethasone Acetate American Regent, Inc. 2010-04-28
00517-0791-01 1 VIAL, MULTI-DOSE in 1 CARTON (0517-0791-01) / 5 mL in 1 V... Betamethasone Sodium Phosphate and Betamethasone Acetate American Regent, Inc. 2019-11-01
00517-0799-01 1 VIAL, MULTI-DOSE in 1 CARTON (0517-0799-01) / 5 mL in 1 V... Betamethasone Sodium Phosphate and Betamethasone Acetate American Regent, Inc. 2019-11-01
76420-0007-05 5 mL in 1 VIAL, MULTI-DOSE (76420-007-05) Betamethasone Sodium Phosphate and Betamethasone Acetate Asclemed USA, Inc. 2020-01-16
76420-0765-01 1 KIT in 1 CARTON (76420-765-01) * 10 VIAL, SINGLE-DOSE in... Betalido Kit Asclemed USA, Inc. 2014-06-13
76420-0782-01 1 KIT in 1 CARTON (76420-782-01) * 10 mL in 1 VIAL, SINGLE... Marbeta L Kit Asclemed USA, Inc. 2016-05-23
76420-0785-01 1 KIT in 1 CARTON (76420-785-01) * 10 mL in 1 VIAL, SINGLE... Marbeta 25 Kit Asclemed USA, Inc. 2016-05-23
76420-0892-01 1 KIT in 1 CARTON (76420-892-01) * 10 VIAL, SINGLE-DOSE in... BL-C Kit Asclemed USA, Inc. 2024-12-31
78206-0118-01 1 VIAL, MULTI-DOSE in 1 BOX (78206-118-01) / 5 mL in 1 VIAL... CELESTONE SOLUSPAN Organon LLC 2021-06-01
80425-0223-01 1 KIT in 1 CARTON (80425-0223-1) * 10 VIAL, SINGLE-DOSE in... Betalido Kit Advanced Rx Pharmacy of Tennessee, LLC 2023-05-10
80425-0533-01 1 KIT in 1 CARTON (80425-0533-1) * .9 mL in 1 PACKET (6777... Marbeta L Kit Advanced Rx of Tennessee, LLC 2025-06-02
85766-0070-05 1 VIAL, MULTI-DOSE in 1 BOX (85766-070-05) / 5 mL in 1 VIAL... CELESTONE SOLUSPAN Sportpharm LLC 2025-10-01
Observed labelers: Asclemed USA, Inc. (5) · American Regent, Inc. (3) · Advanced Rx of Tennessee, LLC (1) · Advanced Rx Pharmacy of Tennessee, LLC (1) · Organon LLC (1) · Sportpharm LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0702 Betamethasone acet&sod phosp 4 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.